Anti-cancer Therapies in Adults and Their Effects on Cardiovascular System: A Review

References (66)

1. 1 The retinoblastoma protein and cell cycle control [DOI]
2. 2 Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update [DOI]
3. 3 Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer [DOI]
4. 4 Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma [DOI]
5. 5 EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [DOI]
6. 6 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial [DOI]
7. 7 Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations [DOI]
8. 8 Adjuvant Docetaxel for Node-Positive Breast Cancer [DOI]
9. 9 Cardiovascular Toxic Effects of Targeted Cancer Therapies [DOI]
10. 10 Immune checkpoint inhibitors and cardiovascular toxicity [DOI]
11. 11 Comprehensive molecular portraits of human breast tumours [DOI]
12. 12 Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance [DOI]
13. 13 Cyclin D1 in Breast Cancer Pathogenesis [DOI]
14. 14 Monoclonal Antibodies: A Review [DOI]
15. 15 Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease [DOI]
16. 16 Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision [DOI]
17. 17 Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer [DOI]
18. 18 Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study [DOI]
19. 19 A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity [DOI]
20. 20 Randomized Controlled Trial of Intensity-Modulated Radiotherapy for Early Breast Cancer: 5-Year Results Confirm Superior Overall Cosmesis [DOI]
21. 21 Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation [DOI]
22. 22 Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway [DOI]
23. 23 Acrolein Can Cause Cardiovascular Disease: A Review [DOI]
24. 24 West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer [DOI]
25. 25 Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy [DOI]
26. 26 Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved [DOI]
27. 27 Cardiovascular Changes in Menopause [DOI]
28. 28 Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer [DOI]
29. 29 Update on cardiotoxicity of anti‐cancer treatments [DOI]
30. 30 Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib [DOI]
31. 31 Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database [DOI]
32. 32 Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? [DOI]
33. 33 New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer [DOI]
34. 34 Aromatase Inhibition: Translation into a Successful Therapeutic Approach [DOI]
35. 35 Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab [DOI]
36. 36 Redox Cycling of Catechol Estrogens Generating Apurinic/Apyrimidinic Sites and 8-oxo-Deoxyguanosine via Reactive Oxygen Species Differentiates Equine and Human Estrogens [DOI]
37. 37 Stopping tamoxifen peri-operatively for VTE risk reduction: A proposed management algorithm [DOI]
38. 38 The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer [DOI]
39. 39 Ifosfamide and Cyclophosphamide: Effects on Immunosurveillance [DOI]
40. 40 A Case of Severe Coronary Spasm Associated with 5-Fluorouracil Chemotherapy [DOI]
41. 41 First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis [DOI]
42. 42 Clinical experience in breast irradiation with intensity modulated photon beams [DOI]
43. 43 Angina Induced by 5-Fluorouracil Infusion in a Patient with Normal Coronaries [DOI]
44. 44 The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients [DOI]
45. 45 Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy [DOI]
46. 46 Cardiovascular and Metabolic Toxicity of Abiraterone in Castration-resistant Prostate Cancer: Post-marketing Experience [DOI]
47. 47 Cardiovascular effects of treatment with taxanes [DOI]
48. 48 Anthracycline Chemistry and Biology II [DOI]
49. 49 Selective oestrogen receptor modulators [DOI]
50. 50 Targeted cancer therapies [DOI]
51. 51 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice [DOI]
52. 52 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) [DOI]
53. 53 Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up [DOI]
54. 54 Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association [DOI]
55. 55 Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer [DOI]
56. 56 Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis [DOI]
57. 57 Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer [DOI]
58. 58 Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk? [DOI]
59. 59 Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting [DOI]
60. 60 Safe perioperative tamoxifen use in autologous breast free flap reconstruction: systematic review and meta-analysis [DOI]
61. 61 Prevention and treatment of anthracycline-induced cardiotoxicity: A bibliometric analysis of the years 2000–2023 [DOI]
62. 62 Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review [DOI]
63. 63 Radiation treatment in prostate cancer: covering the waterfront [DOI]
64. 64 Comparing the Efficacy of Carvedilol and Celecoxib to Prednisolone in Acetic Acid-Induced Ulcerative Colitis in Male Albino Rats [DOI]
65. 65 Myocarditis Induced by Immunotherapy: A Rare but Fatal Complication [DOI]
66. 66 Cardiovascular Diseases (CVDs) [DOI]

Cited by 0

No indexed citations yet.

Related research

• Cardioprotective Effect of Scleria lithosperma on Doxorubicin-induced Cardiotoxicity in Wistar Albino Rats — shares topic coverage
• Doxorubicin-Induced Cardio Toxicity in Albino Rats Protected by Adansonia Digitata (Baobab) Leaf Extract — shares topic coverage
• Effect of Grape Seeds (Vitis vinifera L.) and Mandarin Peels (Citrus reticulate L.) Extracts on the Cardiotoxicity Induced by Cyclophosphamide in Rats — shares topic coverage
• Effects of Aqueous and Ethanolic Extracts of Entandrophragma angolense, Cola nitida and Gomphrena celosioides against Doxorubicin-induced Cardiotoxicity in Rats — shares topic coverage
• Assessment of Cardioprotective Effects of Aqueous and Ethanolic Extracts of Stem Barks from Trichilia emetica against Cardiotoxicity Induced by Doxorubicin in Wistar Rats — shares topic coverage